2016
DOI: 10.5604/20828691.1220902
|View full text |Cite
|
Sign up to set email alerts
|

Maintenance chemotherapy with pemetrexed in patients with malignant pleural mesothelioma – case series and review of the literature

Abstract: Malignant pleural mesothelioma is a rare neoplasm with poor prognosis. Surgical complete resection, which is the only radical therapy available, is only possible in a minority of patients who suffer from a locally advanced disease. Radiotherapy can be considered as an adjuvant therapy after surgery or as supportive treatment in palliative care. Attempts are also made at combining it with chemotherapy. In cases of locally advanced, non-resectable or metastatic disease, chemotherapy remains the treatment of choi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 23 publications
0
3
0
Order By: Relevance
“…3 However, recent clinical evidence demonstrated that benefits of antibiotic prophylaxis of cancer patients outweighed its risks. 4 The simultaneous suppression of pathogenic microorganisms during anticancer chemotherapy could not only interrupt or abolish tumor growth but also eventually protect cancer patients from infection. Hence, the development of novel drugs which exhibit dual anticancer and antibacterial properties in comparable concentration range would affect the malignant process and simultaneously decrease the risk of patients’ death due to infection, febrile neutropenia, and bacteraemia.…”
Section: Introductionmentioning
confidence: 99%
“…3 However, recent clinical evidence demonstrated that benefits of antibiotic prophylaxis of cancer patients outweighed its risks. 4 The simultaneous suppression of pathogenic microorganisms during anticancer chemotherapy could not only interrupt or abolish tumor growth but also eventually protect cancer patients from infection. Hence, the development of novel drugs which exhibit dual anticancer and antibacterial properties in comparable concentration range would affect the malignant process and simultaneously decrease the risk of patients’ death due to infection, febrile neutropenia, and bacteraemia.…”
Section: Introductionmentioning
confidence: 99%
“…Despite the fact that the role of the virus and bacteria in the development of cancer is underestimated, antimicrobial prophylaxis during cancer therapy is important for reducing some side effects and the risk of death due to infection [ 55 , 56 ].…”
Section: Resultsmentioning
confidence: 99%
“…[ 49 ] Their administration can decrease some side effects and the risk of patients' death due to infection. [ 50 ] Consequently, substances that simultaneously exhibit both anticancer and antimicrobial activity in a similar range of concentrations are of interest. Previously, it was found that among all 3 d metal coordination compounds with thiosemicarbazones and isothiosemicarbazones, copper(II) shows the highest antibacterial and antifungal activities.…”
Section: Resultsmentioning
confidence: 99%